-
Press Briefing by Director General of NAFDAC, Professor Mojisola Christianah Adeyeye, PhD, FAS on Joint International Destruction of 5X 40 Feet Containers 0f Unregistered Pharmaceuticals Including Tramadol 200mg and Higher Strength
- January 23, 2023
- Posted by: nafdacadmin
- Category: Press Release
No Comments -
Public Alert No. 02/2023 – Alert on Substandard (contaminated) AMBRONOL syrup and DOK-1 Max syrup
- January 15, 2023
- Posted by: nafdacadmin
- Category: Uncategorized
-
Public Alert No. 01/2023 – Alert on Substandard (contaminated) METHOTREXTM 50mg identified in the WHO Eastern Mediterranean region
- January 9, 2023
- Posted by: nafdacadmin
- Category: Recalls and Alerts
-
Second Term Resumption Speech – Continuation Of Transformative Leadership Of NAFDAC
- January 4, 2023
- Posted by: nafdacadmin
- Category: Press Release
-
Reappointment Of Director General Of NAFDAC, Prof. Moji Christianah Adeyeye
- December 30, 2022
- Posted by: nafdacadmin
- Category: Press Release
-
Public Alert No. 050/2022 – Alert on Revoke of Drug Companies Licenses after 159 Infant deaths in Indonesia
- December 20, 2022
- Posted by: nafdacadmin
- Category: Recalls and Alerts
-
Public Alert No. 049/2022 – Alert on the UAE health authority warning against consumption of weight loss pills
- December 20, 2022
- Posted by: nafdacadmin
- Category: Recalls and Alerts
-
Public Alert No. 048/2022 – Warning Against Counterfeit Covid-19 Antigen Rapid Test Kits
- December 14, 2022
- Posted by: nafdacadmin
- Category: Recalls and Alerts
-
Public Alert No. 047/2022 – Alert On The Distribution And Sale Of Falsified Lantus Solostar Solution For Injection In Prefilled Pens 100 I.U
- December 14, 2022
- Posted by: nafdacadmin
- Category: Recalls and Alerts
-
Public Alert No. 046/2022 – Alert on the Distribution and Sale of Falsified Daonil 5mg Tablets
- December 14, 2022
- Posted by: nafdacadmin
- Category: Recalls and Alerts